An Exploratory Study to Evaluate the Penetration of Ceftobiprole Into Soft Tissue Determined by In Vivo Microdialysis in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2012
At a glance
- Drugs Ceftobiprole medocaril (Primary) ; Ceftobiprole
- Indications Enterococcal infections; Methicillin-resistant Staphylococcus aureus infections; Pneumococcal infections; Pseudomonal infections
- Focus Pharmacokinetics
- Sponsors Johnson & Johnson
- 27 Jul 2012 Basilea Pharmaceutica added as trial association and lead trial centre as reported by ClinicalTrials.gov.
- 24 Dec 2009 New trial record